Technology empowering Life
Independently controllable industry chain
of real-world patient usage
Average product iteration cycle
Commercial breakthrough
Left Ventricular Assist Device
The next-generation product NEW-EVA has now entered the validation phase, with multiple successful animal experiments completed. This product is expected to achieve multiple innovative breakthroughs in miniaturized design and pulse control technology, further enhancing implant adaptability and physiological biomimicry, bringing better treatment options to patients with end-stage heart failure.
Learn More
Join EVAHEART — Let Your Heart Beat with the World
Recruitment Entry
Submitted successfully!